William Blair & Company’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-747
| Closed | -$16.7K | – | 1861 |
|
|
2022
Q4 | $16.7K | Hold |
747
| – | – | ﹤0.01% | 1694 |
|
|
2022
Q3 | $15K | Hold |
747
| – | – | ﹤0.01% | 1719 |
|
|
2022
Q2 | $17K | Buy |
747
+1
| +0.1% | +$23 | ﹤0.01% | 1742 |
|
|
2022
Q1 | $20K | Hold |
746
| – | – | ﹤0.01% | 1795 |
|
|
2021
Q4 | $27K | Hold |
746
| – | – | ﹤0.01% | 1832 |
|
|
2021
Q3 | $31K | Sell |
746
-724
| -49% | -$30.1K | ﹤0.01% | 1733 |
|
|
2021
Q2 | $59K | Sell |
1,470
-862
| -37% | -$34.6K | ﹤0.01% | 1672 |
|
|
2021
Q1 | $83K | Hold |
2,332
| – | – | ﹤0.01% | 1616 |
|
|
2020
Q4 | $73K | Buy |
2,332
+20
| +0.9% | +$626 | ﹤0.01% | 1580 |
|
|
2020
Q3 | $64K | Buy |
+2,312
| New | +$64K | ﹤0.01% | 1478 |
|